FIDSSA Quarterly - MyCPD

9
Volume 7, Issue 4 1 st December 2016 FIDSSA Quarterly Newsletter of the Federation of Infectious Diseases Societies of Southern Africa Candida auris: the new superbug on the block SASCM reports urgent need for local guidelines to manage infection caused by Candida auris in South African hospitals Candida auris has recently emerged across the globe as a cause of invasive human infections with a crude mortality ranging from 33% to 72%. Over a thousand patients have had C. auris cultured from diagnostic specimens at public and private laboratories in South Africa, with most cases at hospitals in Johannesburg & Pretoria. A large proportion of these isolates were from normally- sterile site specimens (blood and central venous catheters (CVC). Wound sepsis and otitis have also been described. Patients usually acquire the infection after hospitalization and possible risk factors may include diabetes mellitus, recent Marc Mendelson (President), Andrew Whitelaw (Secretary Treasurer), Nelesh Govender (President-Elect & SASCM), Gary Reubenson (Secretary Treasurer-Elect), Adrian Brink (Past-President), Chetna Govind (SASCM), Joy Cleghorn & Briette du Toit (ICSSA), Nicolette du Plessis & Mark Cotton (SASPID), John Black & Tom Boyles (IDSSA), Lee Baker & Garth Brink (SASTM), Marcelle le Roux & Frans Radebe (STDSSA), Lea Lourens (FIDSSA Administrator – [email protected]) Contents Page 1 Page 2 Page 7 Page 4 SASCM report STDSSA News ICSSA News IDSSA News FIDSSA Executive Committee Page 5 SASPID News Page 6 SASTM News

Transcript of FIDSSA Quarterly - MyCPD

Volume7,Issue4 1stDecember2016

FIDSSAQuarterlyNewsletterofthe

FederationofInfectiousDiseasesSocietiesofSouthernAfrica

Candidaauris:thenewsuperbugontheblock

SASCMreportsurgentneedforlocalguidelinestomanageinfectioncausedbyCandidaaurisinSouthAfricanhospitals

Candidaaurishasrecentlyemergedacrosstheglobeasacauseofinvasivehumaninfectionswithacrudemortalityrangingfrom33%to72%.OverathousandpatientshavehadC.aurisculturedfromdiagnosticspecimensatpublicandprivatelaboratoriesinSouthAfrica,withmostcasesathospitalsinJohannesburg&Pretoria.Alargeproportionoftheseisolateswerefromnormally-sterilesitespecimens(bloodandcentralvenouscatheters(CVC).Woundsepsisandotitishavealsobeendescribed.

Patientsusuallyacquiretheinfectionafterhospitalizationandpossibleriskfactorsmayincludediabetesmellitus,recent

MarcMendelson(President),AndrewWhitelaw(SecretaryTreasurer),NeleshGovender(President-Elect&SASCM),GaryReubenson(SecretaryTreasurer-Elect),AdrianBrink(Past-President),ChetnaGovind(SASCM),JoyCleghorn&BrietteduToit(ICSSA),NicoletteduPlessis&MarkCotton(SASPID),JohnBlack&TomBoyles(IDSSA),LeeBaker&GarthBrink

(SASTM),MarcelleleRoux&FransRadebe(STDSSA),LeaLourens(FIDSSAAdministrator–[email protected])

ContentsPage1

Page2

Page7

Page4

SASCMreport

STDSSANews

ICSSANews

IDSSANews

FIDSSAExecutiveCommittee

Page5

SASPIDNews

Page6 SASTMNews

Volume7Issue4 1stDecember2016

2

surgeryandCVCsorurinarycathetersinsitu.ItispostulatedthatC.aurismightspreadfromcolonizedorinfectedpatientsortheirimmediateenvironment(intowhichtheorganismisshed)tootherpatientsviathehandsofhealthcareworkersoronfomites.Ofgreatconcernisthatthisorganismisusuallyresistanttofluconazole,whichisthefirst-lineantifungalagentusedinmanycentres.Furthermore,recentglobaldataindicatethatmorethan40%ofisolatesareresistanttotwoormoremajorclassesofantifungals.

Unfortunately,thelaboratoryidentificationofC.aurisisdifficultemployingroutinemethods.UsingtheAPIsystems(bioMérieux,France),C.aurismaybemisidentifiedasRhodotorulaglutinis,withAuxacolor(Bio-Rad,USA)asSaccharomycescerevisiaeandwithVITEK-2YSTandVITEKMassSpectrometry(MS)systems(bioMérieux,France)asCandidahaemulonii,CandidasakeandCandidafamata.AsoftwareupgradeforVITEKMSisimmediatelyavailablewhichwouldalleviatetheproblemandtheVITEK-2YSTdatabaseisexpectedtobeupgradedearlynextyear.MALDIBiotypersystem(BrukerCorporation,USA)ormolecularmethodsreliablyidentifythisorganism.AlthoughbreakpointshavenotbeenestablishedforC.auris,antifungalsusceptibilitytestingshouldbeperformedonclinicallysignificantisolatestoguidepatienttherapy.EchinocandinsmaybeusedasempirictherapywithamphotericinBasanalternativeagentinthepublic-sector,untilfullsusceptibilityresultsareavailable.

Infectionpreventionandcontrolmeasuresincludeisolationorcohortingofpatients,standardcontactprecautionsandenvironmentaldecontaminationwithachlorine-releasingsolution.

C.aurisislikelytobeamajorpathogencausinginfectionsinallhospitals.Clinical,laboratoryandinfectionpreventionandcontrolconsensusguidelinesforSAhospitalsareurgentlyneededwiththeinvolvementofmajorstakeholdersfromNICD,SASCM,ICSSA,privateandpublichospitals,privateandNHLSlaboratories,andICUphysicians.SASCMwillendorsethespeedydevelopmentandimplementationoftheseguidelinesoverthecomingmonths.

Weconcludethisyearwithincreasedconcernsonthespreadofmulti-drugresistantorganismsinhospitalswithoneoftheunexpectedandthelatestconcernbeingCandidaauris.

InfectionPreventionandControlrecommendationsare:

Appropriateinfectionpreventionandcontrolmeasures:

o Bare-below-the-elbowspolicymustbeenforcedforallhealthcarepersonnel

o Scrupuloushandhygiene

o Standardprecautions

o IsolationofallpatientscolonizedorinfectedwithC.aurisinasingleroomwithensuitefacilitieswhereverpossible

Volume7Issue4 1stDecember2016

3

o Useofcontactprecautions(glovesandaprons)ifriskofsoilingwithblood/bodyfluids.

o Briefvisitorsabouttheimportanceofhandhygiene&theuseofprotectiveapronsisadvised

o Ahypochloritesolutionshouldbeusedfordisinfectionoftheenvironment,atastrengthof1000ppmavailablechlorine(i.e.higherthanthatroutinelyused)–bothforroutineterminalcleaninganddisinfection.

o Terminalcleaningofthebedspacemustbeperformedafterthepatienthasleft,preferablyusinghydrogenperoxidevapourwherefeasible.

o Particularattentionmustbepaidtocleaningofmultiple-useequipment(e.g.BPcuffs,thermometers,computers/equipmentonwheels,ultrasoundmachines)fromthebedspaceofpatientswithC.auris.

o Ifthepatientneedstogototheatreorradiologyetc.,theyshouldbescheduledlastonthelistforthedayandtheenvironmentcleanedasdescribedabove(i.e.usinghypochloritesolutionatastrengthof1000ppmavailablechlorine).

o Wasteandlinendisposalproceduresasroutineforothermultidrug-resistantorganisms.

o Alertingwards/otherhospitalsontransferofapatientwithC.auris.

o C.auriscolonisationisdifficulttoeradicateandpatientscanremaincolonizedforprolongedperiods,somaycontinuetoposeariskfortransmission.

LastmonthweinterviewedthenewChairoftheGautengInfectionControlSociety(GICS)andreportedbackontheirplansgoingforward.ThisquarterweinterviewedYolandavanZyl,ChairpersonoftheWesternCapeSociety.

“Wehavehadasuccessfulyearwiththesupportofmyteam,includingVidaMorris(treasurer)andMichelleOsborne(Secretary).Wekickedoffwithourfirstmeetingonthe25thFebruaryattheRedCrossHospitalwiththetheme:“Outbreakmanagementandreporting”.SpeakersincludedProfessorMehtarandDoctorDramowski,whospoketousaboutthemanagementofoutbreaks.RNBRhode(Melomed)andRNVMorris(GrooteSchuurHospital)alsosharedtheirexperienceswithoutbreaksattheirinstitutions.

Onthe26thMayweheldoursecondmeetingatAmpathLaboratorieswiththetopic“IPCChallengesinICU”.DrWKleintjiesfromTygerbergHospitalandDrJVanWykfromAmpathsharedtheirknowledgeonthesubject.

Then,onthe25thAugustwehadourthirdmeetingatKarlBremerHospitalwiththetopic:“InfectionControlinEmergencyServices(EMS)andAirMercyServices(AMS)”.Wehadspeakersfrompublicandprivateambulanceservices.WewereveryenlightenedregardingthechallengesthattheyhaveandhowtheytrytomaintainIPCprinciples.Wewereallreadytogoandofferthemourservicesintrainingandsupportwhenwerealizedhowfortunateweareallworkinginstructuredhealthcarefacilitiescomparedtobeingoutthere,“ontheroad”.

Ourfinalmeetingtookplaceon22ndNovemberandthemeetingwasdedicatedtotheannualAGMandfeedbackfromtheICANconference.Thesocietypartiallysponsored(conferencefees)threeWCISmemberstoattendtheICANconferencefromthe25-28September2016inJohannesburg”.

ThankstoYolandaandteamforyourfeedback.

Volume7Issue4 1stDecember2016

4

SAPA2016FathimaNaby,PaediatricIDspecialist,KZN

Thebiennial SouthAfricanPaediatricAssociationandSouthAfricanAssociationofPaediatricsurgeons(SAPA/SAAPS)conferencewashostedinthecoastalcityofeThekwini(Durban)fromthe1-4September2016.Theprogramconstitutedofanarrayofmulti-disciplinaryscientificworkshopsonthe31August2016,whichwaswellattended.

“Infection Prevention and Control (IPC) and Antibiotic Stewardship” was the title of the Southern AfricanPaediatric InfectiousDiseaseSociety (SASPID)workshopwiththethreesessionschairedbyProfNicoletteduPlessis,DrMelissaLawlerandDrMoArchary.

ProfduPlessissetthestage,byopeningthesessionwithaninteractivecasediscussion.DrAngelaDramowski(Stellenbosch) presented a South African perspective on Health-care associated infections with a practicalguideline for clinicians to investigateandmanageHAI inbusypaediatricunits suchas ICU/NICUs.Paediatricdata show an increase in multidrug-resistant HAIs, emphasizing the importance of implementing andmaintaining IPC practices in paediatric services. Amicrobiologist perspective on strategies to preventMDRorganism spread and decreasing antimicrobial resistance in HAIs was presented by local KZN experts ProfMoodleyandDrCGovind.

Part of IPC practice is appropriate and prompt outbreak investigation andmanagement. An approach to apatientwith suspectedHAI (Dr FathimaNaby, Pietermaritzburg), practical outbreak investigation (DrAngelaDramowski)andethicsofoutbreakreporting(ProfNicoletteduPlessis)werecoveredinthissession.Thefinalsession highlighted important factors when deciding about the duration of antibiotic therapy (Dr UteHallbauer)andutilizingtherapeuticdrugmonitoringinPaediatricpractice.DrRamsamy,amicrobiologistfromPrinceMshiyeniHospitalputintoperspectivetheroleofthemicrobiologylaboratoryinHAI.ProfNicoletteduPlessis and Dr Melissa Lawler addressed the challenges in paediatric antimicrobial stewardship and put aproposalforwardofwheretostartwithantibioticstewardshipintheSouthAfricancontext.

Thoughtsabout2016…(NicoletteduPlessis)

SASPIDwould liketowelcomeallnewlyqualifiedpaediatric IDspecialist in2016andwishallcurrent fellowsthebestofluckwiththeirstudies.WeareencouragedbytheincreasingpaediatricIDexpertiseinSA.

Paediatric IPC and antimicrobial stewardship are important focus areas that the executive members haveidentified and will support in the future. This focus area will also be at the African Society of PaediatricInfectiousDiseases(AfSPID)meetings.

SASPIDmemberscontinuetobeauthoritiesinthefieldsofHIVmanagementofnewborns,HIVinadolescence,newTBdrugsandtreatmentdurationandvaccine-preventablediseases.

Volume7Issue4 1stDecember2016

5

STDSSAReportonBacterialvaginosisContribution:RudzaniMathebula:FELTPResidentStudent-STIUnit–NICD

Bacterial vaginosis (BV) is a vaginal infection that occurs when there is overgrowth of anaerobic relatedorganisms suchasGardnerella vaginalis,Atopobiumspp,Provetella spp,Mycoplasma sppandMobiluncusspp in the vagina.1 The overgrowth of these organisms replaces lactobacilli and increases the pH of thevagina.2 Risk factors that are associated with BV include young age, multiple sex partners, a new sexualpartner,perfumedsoaps,douching,smokingandIUDascontraceptive.3Approximately50%ofwomenwhopresentwithBVareasymptomaticandthereforedonotshowanysymptomsoftheinfection.4TheotherhalfwithsymptomsofBVpresentswithincreaseddischargeandafishyodor.1

BViscurablewithsyndromicmanagementhowever,itoftendevelopsintoarecurrentdisease.3Trialstudiesconductedontheeffectivenessofmetronidazolereportacurerateof80%to90%inthefirstmonth,andrecurrenceratesof30%at3monthsand50%at12months.1,3It isassumedthatrecurrentinfectionofBVoccurstowardsmenstruationwherethevaginalPHlevelishighandoestrogenislow.3RecurrentinfectionofBV isassociatedwithseriousriskswhichmay includepretermlabour,sexuallytransmittedinfections(STIs)such as gonorrhoea or chlamydia, human immunodeficiency virus (HIV) and pelvic inflammatory disease(PID).4,5A cohort studyconducted inUganda found recurrentepisodesofBVat58%after treatmentwithmetronidazolewhich suggest prolonged period of infectiousnesswhich increase susceptibility to STIs andHIV.5

ThemanagementofrecurrentBVisdifficultbecausetheaetiologyandtransmissionofthediseaseispoorlyunknown.2,3,4 Furthermore, there is no optimal management strategy exclusive for recurrent BV. Eventreatment of a sexual partner demonstrated no benefit in the reduction of recurrent infection amongwomen.2TheSouthAfricantreatmentguidelinesofSTIadvocatetheuseofasingledoseofmetronidazolehoweverdoesn’tprovidetreatmentoptionforrecurrentBV.SomestudiessuggestasimultaneoustreatmentofprobiotictogetherwithmetronidazolegeltobeeffectiveinthemanagementofrecurrentBVcomparedtojustmetronidazolealone.6However,furtherclinicaltrialsintotheusefulnessofthisapproachareneeded.Inthemeantime,behaviouralchangeandproperhealtheducationaboutSTIsshouldbeencouragedathealthfacilitiestoensurewomenunderstandtherisksandhowtoprevent furthercomplications.FocusedeffortsarerequiredtoimprovethemanagementofBVtopreventSTIsandHIVinSouthAfrica.

References:

1. MillerM.Recurrentvulvovaginitis:Tipsfortreatingacommoncondition.2014.2. WilsonJ.Managingrecurrentbacterialvaginosis.Sex.Transm.Infect.2004;80(1):8-11.3. TruterI,GrazM.Bacterialvaginosis:Literaturereviewoftreatmentoptionswithspecificemphasison

non-antibiotictreatment.AfricanJournalofPharmacyandPharmacology.2013;7(48):3060-7.4. BradshawCS,SobelJD.Currenttreatmentofbacterialvaginosis—limitationsandneedforinnovation.

J.Infect.Dis.2016;214(suppl1):S14-S20.5. FrancisSC,LookerC,VandepitteJ,BukenyaJ,MayanjaY,NakubulwaS,etal.Bacterialvaginosis

amongwomenathighriskforhivinuganda:Highrateofrecurrentdiagnosisdespitetreatment.Sex.Transm.Infect.2016;92(2):142-8.

6. MenardJ-P.Antibacterialtreatmentofbacterialvaginosis:Currentandemergingtherapies.Internationaljournalofwomen'shealth.2011;3:295-305.

Volume7Issue4 1stDecember2016

6

SASTMNews

TravelHealthAfrica:theboilingpoint?

SASTMwastheproudhostofthe7thRegionalConferenceoftheInternationalSocietyofTravelmedicineheldattheBoardwalk,PortElizabethinSeptember.Nationalandinternationaldelegateswereprivilegedtoattendoutstandingpresentationsgivenbylocalandinternationalspeakers.Notonlywereinfectiousdiseasesdiscussedbutothertopicscoveredincludedthetravellerwithdisabilities,thetravellerwithend-stagedisease,thecaveatsoftravelinsurance,towardrabieseliminationinAfricaandthe“ThirdCultureKid”.

ProfessorMichaelMuehlenbeinfromtheUnitedStatesconvenedanexcellentsymposiumonOneHealthwhichisthefirsttimethatsuchatopichasbeenincludedinaSASTMCongress.SuchwastheinterestthataOneHealthSpecialInterestGrouphasbeenformedwithinSASTM.

Itwasanexhilaratingandinspirationalmeetingof250colleagues.

TheOlderTraveller–aguideforthehealthprofessional

Eightyisthenewsixty!Peopleareageingmoresuccessfullyandremainphysicallyandmentallyactiveforlonger.

SASTM, in collaboration with the South African GeriatricSociety (SAGS) and the International Association for MedicalAssistance to Travellers (IAMAT www.iamat.org) has recentlypublished “The Older Traveller – a guide for the healthprofessional”.

This Guide provides clinicians advice on health issuesencountered by older travellers and practical information onhow tocounselolderpersons for travel.Chapters include thephysiology of ageing, prescribing for the elderly,immunosenescence, venous thromho-embolism, yellow fevervaccination in the elderly, chronic disease and the oldertraveler,travellingwithdementia,andmore.

For further information and to order a copy, visitwww.sastm.org.za

Volume7Issue4 1stDecember2016

7

StrengtheningHealthSystems&capacitytodiagnoseandmanageTBandARTFailure–experiencefromKZN

Theadvancedclinicalcare(ACC)programmehasestablished5toll-freehelplineswereestablishedtofacilitatetimelyupreferralsforcomplexTBandHIVpatientsandprovidespecialistclinicalsupportandadvicetohealthfacilities.Thepurposeofthetoll-freehelplinesistostrengthenreferralpathwaysandenhancedirectedmentorshipandsupportforclinicaldecisionmaking.ThehelplinesprovideassistancewithimmediateadviceforthediagnosisandmanagementofcomplicatedHIV-TBcasesaswellasfacilitate

timeousreferralofpatientstothemostappropriatereferralsitebybridgingthecommunicationgapbetweenspecialistsandprimarycareanddistrictlevelhealthcareproviders.TheMDRTBbookingline,isthemostpopularandbusiestofthehelplines.ThishelplinereducedwaitingtimesforreferraltoKingDinuzuluHospitalfrom6weeksto7days.Additionally,therehasbeensignificantuptakeofthenewlyintroducedAdultInfectiousDiseasesHelplineThenumberofdecentralizedtreatmentsitesfordrugresistance(DR)TBservicesincreasedfromfourto19sitesinKZN.ThiswascompletedthroughaprogramofactivitiesthatincludedmentorshipoutreachsupportbyexpertDRTBtreatmentdoctors,implementationofatollfreehealthcareworkerhelpline,aclinicbookingline,clinicianandnursementorshipandsupport,multidisciplinarytrainingofallhealthcareworkersmanagingDRTBandHIVco-infectionatdecentralizedandsatellitesites.ACCTrainingsareCPD(continuingprofessionaldevelopment)accreditedbytheUniversityofKwaZulu-NatalandservesasanincentiveforHCWstoattendtrainings.Atotalof423Doctors,200Pharmacists,365Nurses,33ProgramManagersand39otherstaffcategoriesreceivedAdvancedClinicalCaretraininginHIVandTBDrugResistanceandComplexHIVdiseasemanagement.HealthsystemsstrengtheningtoimproveviralloadsuppressionratesandtriageofpatientswithcomplicatedpatientsisongoingwiththeaimwastoimprovetimeousdetectionandaccesstosecondandthirdlineARTintheprovince.

InothernewsfromKZN:DrJadeMogamberryhasrelocatedtoNgwelazanaasofthe1November2016.ShehasjoinedDrThandiManzini(infectiousdiseasesspecialistphysician).ThiswillenablefurtherdevelopmentofanInternalMedicineandinfectiousdiseasesservicesinNorthernKwazuluNatal.

Finally,CONGRATULATIONStoDrArifaParkerofTygerbergHospital,whopassedCertID(SA)PhysandbecomesSouthAfrica’snewestIDSpecialist!

ANDFINALLY

Theendofanotheryear,givestimetopauseandsaythankyoutoallthecontributorstoourFIDSSAQuarterlynewsletter.Itiswonderfultohearmorevoicesthanbefore,andwewouldliketoencourageallmemberstobeactiveinthefederationanditssocietiessoastosharetheworkloadandtogainfreshopinionsandperspectives.

WewishyouandyourfamiliesaveryhappyfestiveseasonaheadandhopethatyougetsomeR&Rsothat2017willbeabumperyearforyouall!

TheFIDSSATeam

Volume7Issue4 1stDecember2016

9